ArticleJapanese journal of clinical oncology2026

Protocol digest of a randomized phase III study of pola-R-CHP/high-dose methotrexate/IT vs. pola-R-CHP/IT for newly diagnosed diffuse large B-cell lymphoma with high risk of central nervous system relapse: JCOG2201 (PREMIER).

Yusuke Sano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.